Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Terranueva Corporation (C:TEQ)

Business Focus: Biotechnology & Medical Research (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for TEQ within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Feb 06, 2024 06:57 ET
Canadian Investment Regulatory Organization Trading Halt - TEQ
VANCOUVER, BC, Feb. 6, 2024 /CNW/ - The following issues have been halted by CIRO:
Read full article
Jan 22, 2024 18:25 ET
Terranueva annonce le résultat favorable de l’assemblée des créanciers tenue suite au dépôt d’un avis d’intention
Terranueva Corporation (CSE: TEQ) (« Terranueva » ou la « Société ») est heureuse d’annoncer que l’assemblée des créanciers tenue aujourd’hui a accepté à 86% la proposition de règlement (le « Règlement ») qui leur a été soumise. De plus, les...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.99
--
--
Price to Sales - TTM
--
2.92
4.02
Price to Book - most recent quarter
2.04
2.81
2.10
Price to Cash Flow per share - TTM
--
8.98
10.51
Price to Free Cash Flow per share - TTM
--
--
12.79
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Apr 15, 20241,5000
Mar 31, 20241,5000
Mar 15, 20241,5000
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Terranueva Corporation is a Canada-based cannabis company. The Company is focused on providing medicinal and recreational cannabis to the Canadian and international markets. It is engaged in research and development focused on the cannabis industry. The Company is also focused on implementing a modular production approach in its process automation. The Company's wholly owned subsidiary is Terranueva Pharma Corporation.

See business summary

 

Twitter

Search (past week) for $TEQ.CA

  • No tweets found